Clin2
NCT04332341Possibly a fitRecruiting

Nicotinamide riboside during bone marrow transplant

Allogeneic Hematopoietic Cell Transplantation

Treatments studied

Part of Blood & lymphatic clinical trials.

This trial studies whether a supplement called nicotinamide riboside (a vitamin-like product) can be given safely during allogeneic bone marrow transplant. It may help researchers understand how well it works and how it affects recovery for people getting a donor transplant.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are planning an allogeneic bone marrow transplant for a qualifying blood cancer, but not myelofibrosis
  • Your transplant plan includes strong (myeloablative) conditioning to prepare for the donor transplant
  • You have a donor whose tissue type matches closely (HLA-identical related donor or unrelated donor) and you will receive bone marrow as the graft
  • You can sign a consent form to join the study
  • You have no known allergy or intolerance to nicotinamide riboside ingredients, including niacin or nicotinamide

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05194397Recruiting· Phase 2
Exercise plus NR supplement to boost fitness after stem-cell transplant

This trial tests whether a supervised exercise program, plus an NR supplement, can improve fitness in young people who have had an allogeneic (donor) stem-cell transplant for certain blood cancers or bone marrow conditions. It’s meant to help with energy and physical ability while monitoring safety.

Duarte, California
NCT05732051Recruiting· Phase 2
Nicotinamide riboside to protect the heart during breast cancer chemo

This trial tests whether nicotinamide riboside can help prevent heart problems caused by a common breast-cancer chemotherapy (anthracyclines). If you’re eligible, you’ll be followed to see how your heart is doing during treatment.

Lørenskog, Akershus
NCT07579429Recruiting· Phase 2
Nicotinamide Riboside Supplement for MDS

This trial tests whether a supplement called nicotinamide riboside can help people with a blood disorder called MDS (myelodysplastic syndrome) or early warning signs of it. The supplement is meant to support your bone marrow's ability to make healthy blood cells.

Aurora, Colorado
NCT07693543Not yet recruiting· Phase 2
Nicotinamide riboside supplement for chronic kidney disease

This trial tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if it can slow down kidney function decline and improve overall health.

San Diego, California
NCT06425042Recruiting
Nicotinamide riboside with exercise for healthy aging

This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.

Santiago, Santiago Metropolitan
NCT06521307Not yet recruiting
Nicotinamide riboside for kidney protection during heart surgery

This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can help protect your kidneys during heart valve surgery. You may qualify if you are scheduled for this surgery and meet a few health requirements.

México

Hear when a new Allogeneic Hematopoietic Cell Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.